Results 151 to 160 of about 1,702,455 (203)

Real-world effectiveness of fostamatinib in patients with immune thrombocytopenia: a single-center retrospective study. [PDF]

Int J Hematol
Fujimaki K, Takeda T, Kawabata K, Bouno A, Nakajima Y, Nakajima H.   +5 more
europepmc   +1 more source

Secondary Evans Syndrome Associated with Localized Clear Cell Renal Cell Carcinoma: A Case Report and Brief Literature Review. [PDF]

Eur J Case Rep Intern Med
Peña Monge EM, Carrasco-Randrianarison N, Ponte-Fernandez K.   +2 more
europepmc   +1 more source

Thrombopoietin receptor agonists in inherited thrombocytopenias: an evolving mosaic of evidence. [PDF]

Res Pract Thromb Haemost
Zaninetti C.
europepmc   +1 more source

Preliminary experience with oral thrombopoietin-receptor agonists, primarily hetrombopag, in pediatric immune thrombocytopenia: a pilot single-center retrospective report. [PDF]

Transl Pediatr
Zhang M, Wang Y, Liang H, Zhang L.
europepmc   +1 more source

Post-ERCP Outcomes in Cirrhotics Patients With Thrombocytopenia: A Propensity-Matched Retrospective Comparative Analysis. [PDF]

J Gastroenterol Hepatol
Gilani SAZ, Naseer M.
europepmc   +1 more source

New thrombopoietin receptor agonist: avatrombopag

Japanese Journal of Thrombosis and Hemostasis
openaire   +1 more source

Patient Preferences and Experiences Regarding Thrombopoietin-Receptor Agonists for Immune Thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE Study)

Hematology, 2021
To establish the experiences with and preferences towards existing thrombopoietin-receptor agonist (TPO-RA) treatments of individuals with immune thrombocytopenia (ITP) in the UK and Ireland, based on treatment attributes.
Jameel Nazir, Vickie McDonald
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Thrombopoietin-Receptor Agonists for Immune Thrombocytopenia

New England Journal of Medicine, 2011
To the Editor: In response to the review by Imbach and Crowther (Aug. 25 issue)1 of thrombopoietin-receptor agonists for primary immune thrombocytopenia: we would like to draw attention to the fact...
Arend Jan Gerard Jansen, Peter A W Te Boekhorst, A J Gérard Jansen   +2 more
exaly   +4 more sources

New Benzimidazoles as Thrombopoietin Receptor Agonists

Bioorganic and Medicinal Chemistry Letters, 2006
A novel benzimidazole series of small-molecule thrombopoietin receptor agonists has been discovered. Herein, we discuss the preliminary exploration of structure-activity relationships within this chemotype.
Richard M Keenan, Connie L Erickson-Miller, Dirk A Heerding   +2 more
exaly   +3 more sources